. Author manuscript; available in PMC: 2018 Nov 12.

Published in final edited form as: Mov Disord. 2012 Oct 31;27(13):1683–1685. doi: 10.1002/mds.25181

Table 1.

Demographics and clinical characteristics


Patients (n)		40
Gender (male/female, n)		16/24
MSA-P/C (n)		26/14
MSA-possible/probable (n)		8/32
Age at onset, years (mean ± SD)		57.0 ± 8.5
Disease duration, years (mean ± SD)		6.0 ± 4.2
H & Y stage, median (range)		4 (2 – 5)
3-point severity scale (n)		5 / 13 / 22
UMSARS (mean ± SD, median, IQR)		52.3 ± 18.3, 53.5, 31.0
	UMSARS ADL (mean ± SD, median, IQR)	25.8 ± 9.6, 25.0, 16.0
	UMSARS ME (mean ± SD, median, IQR)	26.5 ± 9.6, 25.5, 13.5

MSA-P/C … multiple system atrophy-parkinsonian subtype/cerebellar subtype; H & Y stage … Hoehn & Yahr staging (0 – 5); 3-point severity scale … mild / moderate / severe; UMSARS … Unified MSA rating scale (0 – 104); UMSARS ADL … UMSARS subscale “Activities of daily living” (0 – 48); UMSARS ME … UMSARS subscale “Motor examination” (0 – 56)